If GLP-1 analog drugs are being submitted as biosimilars, they also require a comparability assessment with the reference drug, including threshold evaluations and examination of parameters such as drug tolerance
Research shows that 25 to 40% of weight lost on GLP-1 medications like semaglutide and tirzepatide can come from lean muscle tissue, not fat
The FDA approved semaglutide for type 2 diabetes and weight loss in people with obesity or overweight with at least one weight-related health condition
This is why weight regain after stopping semaglutide is so common in the research, occurring in three to six months for many users
Cape Fear Physical Medicine and Rehab emphasizes individualized care and a holistic approach to health
The instructions, he noted, indicate that the recommended serving size is dependent on the experience of the user